- Home
- ENVB vs SNES Comparison
ENVB vs SNES Comparison
Compare ENVB & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- SNES
- Stock Information
- Founded
- ENVB 1994
- SNES 2004
- Country
- ENVB United States
- SNES United States
- Employees
- ENVB N/A
- SNES N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- ENVB Health Care
- SNES Industrials
- Exchange
- ENVB Nasdaq
- SNES Nasdaq
- Market Cap
- ENVB 3.1M
- SNES 6.7M
- IPO Year
- ENVB N/A
- SNES 2016
- Fundamental
- Price
- ENVB $1.23
- SNES $4.95
- Analyst Decision
- ENVB Strong Buy
- SNES Strong Buy
- Analyst Count
- ENVB 1
- SNES 1
- Target Price
- ENVB $10.00
- SNES $10.00
- AVG Volume (30 Days)
- ENVB 180.1K
- SNES 262.7K
- Earning Date
- ENVB 08-11-2025
- SNES 08-07-2025
- Dividend Yield
- ENVB N/A
- SNES N/A
- EPS Growth
- ENVB N/A
- SNES N/A
- EPS
- ENVB N/A
- SNES N/A
- Revenue
- ENVB N/A
- SNES $1,927,000.00
- Revenue This Year
- ENVB N/A
- SNES $130.53
- Revenue Next Year
- ENVB N/A
- SNES $80.00
- P/E Ratio
- ENVB N/A
- SNES N/A
- Revenue Growth
- ENVB N/A
- SNES 40.15
- 52 Week Low
- ENVB $1.01
- SNES $1.30
- 52 Week High
- ENVB $11.55
- SNES $6.48
- Technical
- Relative Strength Index (RSI)
- ENVB 43.28
- SNES 75.55
- Support Level
- ENVB $1.19
- SNES $3.56
- Resistance Level
- ENVB $1.32
- SNES $5.43
- Average True Range (ATR)
- ENVB 0.07
- SNES 0.50
- MACD
- ENVB 0.01
- SNES 0.15
- Stochastic Oscillator
- ENVB 29.41
- SNES 82.42
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.